We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Type
- ARTG (88)
- Cancellation by sponsor (27)
- Prescription medicine registration (19)
- Australian public assessment report (AusPar) (11)
- Section 14, TGO91 consent (3)
- Designation or determination (2)
- Prescription medicine decision summary (2)
- Prescription medicine evaluation (2)
- Cancellation or suspension (1)
Sponsor content
155 result(s) found, displaying 11 to 20
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RYALTRIS olopatadine 600 microgram/actuation and mometasone furoate 25 microgram/actuation nasal spray bottle.
-
Prescription medicine registrationActive ingredients: Influenza virus haemagglutinin.
-
Prescription medicine registrationActive ingredients: Influenza virus haemagglutinin.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CSL Bulk Influenza Vaccine (Split virion, inactivated) Thiomersal-free.
-
Australian public assessment report (AusPar)Onakta (tirbanibulin) was approved for the topical field treatment of actinic keratosis of the face or scalp in adults.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Panvax H5N8 pre-pandemic, Pre-pandemic influenza vaccine (split-virion, inactivated) 10 mL multi-dose injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FLUAD QUAD prefilled syringe(Influenza Surface Antigen,MF59C.1 adjuvanted vaccine).
-
Prescription medicine decision summaryOnakta (tirbanibulin) is indicated for the topical field treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis of the face or scalp in adults.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TAVNEOS avacopan 10 mg hard capsule bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for KORSUVA difelikefalin (as acetate) 50 microgram/1 mL solution for injection vial.